TEL/AML1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL

被引：8
作者：
Fronkova, E
Madzo, J
Zuna, J
Reznickova, L
Muzikova, K
Hrusak, O
Stary, J
Trka, J
机构：
[1] Charles Univ Prague, Dept Paediat Haematol Oncol, Med Sch 2, Prague 15006 5, Czech Republic
[2] Charles Univ Prague, Dept Immunol, Med Sch 2, Prague 15006 5, Czech Republic
[3] Charles Univ Prague, CLIP, Med Sch 2, Prague 15006 5, Czech Republic
来源：
LEUKEMIA | 2005年 / 19卷 / 07期
关键词：
D O I：
10.1038/sj.leu.2403759
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1296 / 1297
页数：2
相关论文
共 8 条
[1]  
de Haas V, 2002, BRIT J HAEMATOL, V116, P87
[2]   Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia [J].
Drunat, S ;
Olivi, M ;
Brunie, G ;
Grandchamp, B ;
Vilmer, E ;
Bièche, I ;
Cavé, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) :281-289
[3]   Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia -: Prospective real-time quantitative reverse transcriptase-polymerase chain reaction study [J].
Madzo, J ;
Zuna, J ;
Muzíkova, K ;
Kalinová, M ;
Krejcí, O ;
Hrusák, O ;
Otová, B ;
Stary, J ;
Trka, J .
CANCER, 2003, 97 (01) :105-113
[4]   Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets -: Report of the BIOMED-1 CONCERTED ACTION:: Investigation of minimal residual disease in acute leukemia [J].
Pongers-Willemse, MJ ;
Seriu, T ;
Stolz, F ;
d'Aniello, E ;
Gameiro, P ;
Pisa, P ;
Gonzalez, M ;
Bartram, CR ;
Panzer-Grümayer, ER ;
Biondi, A ;
San Miguel, JF ;
van Dongen, JJM .
LEUKEMIA, 1999, 13 (01) :110-118
[5]   Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage [J].
Szczepanski, T ;
Pongers-Willemse, MJ ;
Langerak, AW ;
Harts, WA ;
Wijkhuijs, AJM ;
van Wering, ER ;
van Dongen, JJM .
BLOOD, 1999, 93 (12) :4079-4085
[6]   Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia comparison with antigen receptor-based MRD quantification methods [J].
Taube, T ;
Eckert, C ;
Körner, G ;
Henze, G ;
Seeger, K .
LEUKEMIA RESEARCH, 2004, 28 (07) :699-706
[7]   Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects [J].
van der Velden, VHJ ;
Hochhaus, A ;
Cazzaniga, G ;
Szczepanski, T ;
Gabert, J ;
van Dongen, JJM .
LEUKEMIA, 2003, 17 (06) :1013-1034
[8]   Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia [J].
Verhagen, OJHM ;
Willemse, MJ ;
Breunis, WB ;
Wijkhuijs, AJM ;
Jacobs, DCH ;
Joosten, SA ;
van Wering, ER ;
van Dongen, JJM ;
van der Schoot, CE .
LEUKEMIA, 2000, 14 (08) :1426-1435
1